4.7 Article

miR-145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update

Pui-Wah Choi et al.

Summary: This review focuses on the dysregulation of miRNAs in the pre-stage of cervical cancer. Several dysregulated miRNAs have been identified and found to be associated with the DNA damage response and cell growth response induced by human papillomavirus (HPV) infection. However, discrepancies in sample types, HPV status, expression measurement, and analysis methods have led to non-aligned results across studies. This review provides insight into identifying miRNAs involved in early pathogenic processes and highlights their potential as biomarkers for cervical pre-cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

The role of ROS in tumour development and progression

Eric C. Cheung et al.

Summary: Eukaryotic cells have complex systems to regulate reactive oxygen species (ROS), which are deregulated in cancer cells. ROS also modulate the tumor environment and affect stromal cells supporting metabolism, blood supply, and immune responses. The response to ROS is complex and depends on multiple factors, including ROS characteristics and tumor characteristics. Understanding the complexity of ROS in cancers is key to developing ROS-targeting therapies for cancer treatment.

NATURE REVIEWS CANCER (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1

Weitao Yao et al.

Summary: The study revealed that TNK2-AS1 can elevate WDR1 expression in OS cells by 'sponging' miR-4319, thereby promoting the development of OS.

CANCER SCIENCE (2021)

Article Oncology

circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling

Jun Wan et al.

Summary: miR-423-5p inhibits osteosarcoma glycolysis, proliferation, migration, and metastasis by targeting and suppressing Wnt5a/Ror2 signaling pathway. Meanwhile, circPVT1 promotes these processes by acting as a sponge of miR-423-5p.

CANCER SCIENCE (2021)

Article Oncology

A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer

Feifan Wang et al.

Summary: This study confirmed the upregulation and important roles of TAZ in bladder cancer, and discovered a novel positive feedback loop between TAZ and miR-942-3p that regulates biological functions via GAS1 expression. These findings suggest that TAZ, miR-942-3p, and GAS1 could be potential therapeutic targets for bladder cancer treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway

Shuya Yang et al.

Summary: Elevated BAP31 in cervical cancer is regulated by miR-362, which inhibits cell proliferation and promotes apoptosis, ultimately suppressing tumor progression. The BAP31/SPTBN1 complex modulates tumor progression through the Smad 2/3 pathway under miR-362 regulation.

CANCER MEDICINE (2021)

Article Public, Environmental & Occupational Health

Estimates of the global burden of cervical cancer associated with HIV

Dominik Stelzle et al.

Summary: HIV infection significantly increases the risk of cervical cancer, especially in countries in southern Africa and eastern Africa. The burden of HIV-attributable cervical cancer is substantial, with a significant proportion of new cases diagnosed among women living with HIV.

LANCET GLOBAL HEALTH (2021)

Article Oncology

miRNA dysregulation is an emerging modulator of genomic instability

Ana P. Ferragut Cardoso et al.

Summary: Genomic instability, caused by genetic alterations, leads to tumor heterogeneity and drug resistance, resulting from defects in DNA damage surveillance mechanisms and repair machinery. miRNA dysregulation may play a crucial role in mediating genome instability and carcinogenesis.

SEMINARS IN CANCER BIOLOGY (2021)

Article Oncology

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway

Peixin Dong et al.

Summary: The study demonstrated that in endometrial cancer cells, HK2 promotes the expression of EMT and glycolysis, while DLEU2 activates HK2-driven EMT and glycolysis through different mechanisms. These findings provide important mechanistic insights for potential treatment of endometrial cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Metabolic channeling: predictions, deductions, and evidence

Vidhi Pareek et al.

Summary: Metabolic channeling postulates that enzymes can directly transfer products to each other, increasing flux and isolating intermediates. This concept is supported by physical molecular tunnels, multi-enzyme complexes, and enzyme clusters.

MOLECULAR CELL (2021)

Review Biochemistry & Molecular Biology

The enhancement of glycolysis regulates pancreatic cancer metastasis

Jinshou Yang et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Public, Environmental & Occupational Health

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

Marc Arbyn et al.

LANCET GLOBAL HEALTH (2020)

Article Multidisciplinary Sciences

N6-methyladenosine regulates glycolysis of cancer cells through PDK4

Zihan Li et al.

NATURE COMMUNICATIONS (2020)

Article Oncology

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Elizabeth T. H. Fontham et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biochemistry & Molecular Biology

MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer

Shuya Yang et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Oncology

The Warburg Effect 97 Years after Its Discovery

Rosa Maria Pascale et al.

CANCERS (2020)

Article Cell Biology

BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma

Xiyang Zhang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Multidisciplinary Sciences

The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition

Pablo Tristan-Ramos et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat

Yang Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Medicine, Research & Experimental

MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell line

Navaz Sadeghiyeh et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Multidisciplinary Sciences

MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat

Ida Annunziata et al.

NATURE COMMUNICATIONS (2019)

Review Medicine, General & Internal

Cervical cancer

Paul A. Cohen et al.

LANCET (2019)

Article Multidisciplinary Sciences

The molecular landscape of ETMR at diagnosis and relapse

Sander Lambo et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

Metazoan MicroRNAs

David P. Bartel

Review Pharmacology & Pharmacy

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

Philippe Icard et al.

DRUG RESISTANCE UPDATES (2018)

Article Biotechnology & Applied Microbiology

miR-145 Antagonizes SNAI1-Mediated Sternness and Radiation Resistance in Colorectal Cancer

Yun Zhu et al.

MOLECULAR THERAPY (2018)

Article Oncology

MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells

Xi Zhou et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Oncology

miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis

Longchang Jiang et al.

CANCER RESEARCH (2017)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Biochemistry & Molecular Biology

MicroRNA-145 contributes to enhancing radiosensitivity of cervical cancer cells

Chen Ye et al.

FEBS LETTERS (2015)

Review Biochemistry & Molecular Biology

Cancer's Fuel Choice: New Flavors for a Picky Eater

Gina M. DeNicola et al.

MOLECULAR CELL (2015)

Article Cell Biology

A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression

Nobuhiro Okada et al.

GENES & DEVELOPMENT (2014)

Review Oncology

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Simran S. Sabharwal et al.

NATURE REVIEWS CANCER (2014)

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Review Pharmacology & Pharmacy

The Warburg effect: Insights from the past decade

Mohita Upadhyay et al.

PHARMACOLOGY & THERAPEUTICS (2013)

Review Immunology

Targeting glucose metabolism for cancer therapy

Robert B. Hamanaka et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Review Pathology

MicroRNAs in Cancer

Yong Sun Lee et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

Article Multidisciplinary Sciences

p53 represses c-Myc through induction of the tumor suppressor miR-145

Mohit Sachdeva et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells

I. Martinez et al.

ONCOGENE (2008)

Review Oncology

MYC - TIMELINE Reflecting on 25 years with MYC

Natalie Meyer et al.

NATURE REVIEWS CANCER (2008)